Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

Peptivo vs Queen RX

Peptivo
Graded #330

Lower grade

vs+6.199999999999996
Queen RX
Graded #192

Higher grade

The verdict

Queen RX takes it — 66.3/100 to 60.1/100.

Queen RX grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Queen RX offers compounded GLP-1 treatment (semaglutide, tirzepatide, liraglutide) at $299/quarter (~$100/mo).

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueQueen RX +32
45
77
Dose & formulationQueen RX +4
53
57
Clinical oversightPeptivo +7
76
69
Labs & monitoringPeptivo +12
65
53
FulfillmentQueen RX +1
74
75
Contract termsQueen RX +6
55
61
Peptivo · left barQueen RX · right bar

The numbers

MetricPeptivoQueen RX
WeighScore60.1/10066.3/100
GradeCC
Scorecard rank#330#192
SemaglutideNot disclosed$100/mo (quarterly plan, compounded)
TirzepatideNot disclosedNot disclosed
CoverageCoverage not published45 states
Brand-name accessYesCompounded only
Oral / sublingualInjection onlyInjection only
Peptivo

Graded #330 · C

Strengths

  • Low entry pricing — GLP-1 weight-loss plans starting at $169/mo, with free discreet shipping
  • Same-day provider visits and 24/7 provider messaging; 100% online
  • Compounded in the USA at FDA-registered labs; can also prescribe brand GLP-1 (Ozempic, Wegovy, Zepbound)
  • FSA/HSA eligible with upfront pricing

Where it loses points

  • GLP-1 products use generic names ('GLP-1 Daily Support', 'Weight Loss Boost') — semaglutide/tirzepatide not clearly broken out
  • Compounding pharmacy/lab partner not named
  • Limited published policies (privacy and terms only; no HIPAA notice or refund policy found)
  • Not LegitScript-certified (no certification displayed)
Queen RX

Graded #192 · C

Strengths

  • $299/quarter (~$100/mo) — among the lowest GLP-1 pricing in the dataset
  • Three GLP-1 options: semaglutide, tirzepatide, and liraglutide
  • 45-state coverage

Where it loses points

  • No LegitScript or PCAB accreditation
  • No legal entity name or address disclosed
  • No named pharmacy partners
  • Not available in KS, LA, MS, NM, WV

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard